Investing Profile

Philippe Dro

InvestorVC
Partner at Adjuvant Capital
Photo of Philippe Dro, Partner at Adjuvant Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
2
$300M
CompanyStageDateRound SizeTotal Raised
Memo Therapeutics
Series CNov 2023$28M
Series BFeb 2022$25M
$75M
Co-investors: Hadrien Bouchez (Kurma Partners), Veronica Gambillara Fonck (Pureos Bioventures)